End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34,100 KRW | -7.08% | -13.89% | +196.52% |
2023 | S.Biomedics CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2023 | S.Biomedics CO., LTD. has completed an IPO in the amount of KRW 13.5 billion. | CI |
Sales * | - | Sales 1 * | - | Capitalization | 130B 94M |
---|---|---|---|---|---|
Net income * | - | Net income 1 * | - | EV / Sales * | - |
Net cash position * | - 0 | Net cash position 1 * | - 0 | EV / Sales 1 * | - |
P/E ratio * |
-
| P/E ratio 1 * |
-
| Employees | - |
Yield * |
-
| Yield 1 * |
-
| Free-Float | 70.13% |
1 day | -7.08% | ||
1 week | -13.89% | ||
Current month | +190.96% | ||
1 month | +190.96% | ||
3 months | +308.38% | ||
6 months | +357.72% | ||
Current year | +196.52% |
Managers | Title | Age | Since |
---|---|---|---|
Sae-Il Kang
CEO | Chief Executive Officer | 44 | 18-03-28 |
Dong-Wook Kim
CEO | Chief Executive Officer | 63 | 19-03-30 |
Myung-Soo Cho
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-03-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sae-Il Kang
CEO | Chief Executive Officer | 44 | 18-03-28 |
Dong-Wook Kim
CEO | Chief Executive Officer | 63 | 19-03-30 |
Myung-Soo Cho
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-03-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 34,100 | -7.08% | 1,028,725 |
24-04-29 | 36,700 | +11.04% | 2,527,176 |
24-04-26 | 33,050 | -18.40% | 3,111,853 |
24-04-25 | 40,500 | -8.27% | 2,499,590 |
24-04-23 | 44,150 | +11.49% | 1,961,137 |
End-of-day quote Korea S.E., April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+196.52% | 281M | |
-4.21% | 86.85B | |
+2.76% | 40.16B | |
-16.98% | 31.28B | |
+57.86% | 25.27B | |
-16.24% | 15.33B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
-17.10% | 11.69B | |
+6.89% | 8.83B |
- Stock Market
- Equities
- A304360 Stock